NCT02205567View on ClinicalTrials.gov

Bergamot and Cardio-Metabolic Risk Factors

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Dyslipidemia
Interventions
DIETARY_SUPPLEMENT

Bergamot-derived product

Group 1: 500mg/day Group 2: 1000mg/day

Trial Locations (1)

90127

University Hospital of Palermo, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER

NCT02205567 - Bergamot and Cardio-Metabolic Risk Factors | Biotech Hunter | Biotech Hunter